5 completed, 1 terminated, 1 unknown. 7 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Candidiasis, Oral: new trials by email Literature Review of Candidiasis, Oral trials Research Report on Candidiasis, Oral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CelAgace™ OraRinse Solution for Treatment of Candidiasis silver citrate complex and acemannan - Candidiasis, Oral | Phase 1 / Phase 2 | Unknown | CelaCare Technologies, Inc. | 15 | 2024-09-01 | 2024-02-09 |
| Efficacy of 1% Nanochitosan Solution in the Treatment of Denture Stomatitis 1% Nanochitosan Solution, Nystatin Oral Suspension - Denture Stomatitis, Chronic Atrophic Candidiasis | Phase 2 | Completed | Kerman University of Medical Sciences | 30 | 2016-01-17 | 2026-07-13 |
| Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches Clotrimazole varnish, Clotrimazole troches - Oral Candidiasis, Denture Stomatitis | Phase 2 | Completed | Hadassah Medical Organization | 13 | 2009-03-01 | 2015-03-25 |
| Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis PAC113 - Oral Candidiasis | Phase 2 | Completed | Pacgen Biopharmaceuticals Corporation | 223 | 2008-01-01 | 2008-06-26 |
| Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole L-743,872 - Candidiasis, Oral, HIV Infections | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 70 | 2005-06-24 | |
| A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole Amphotericin B - Candidiasis, Oral, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 70 | 2021-11-01 | |
| A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients Posaconazole, Fluconazole - Candidiasis, Oral, HIV Infections | Phase 2 | Completed | Schering-Plough | 500 | 2005-06-24 |
HIV Infections (3) · AIDS-Related Opportunistic Infections (2) · Stomatitis, Denture (2) · AIDS-Related Complex (1) · Acquired Immunodeficiency Syndrome (1) · Candidiasis (1) · Pharyngeal Diseases (1) · Torulopsis (1)
Bacterial Infections and Mycoses (7) · Infections (7) · Mouth Diseases (7) · Mycoses (7) · Stomatognathic Diseases (7) · Candidiasis (6) · Blood-Borne Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Lentivirus Infections (3) · RNA Virus Infections (3) · Retroviridae Infections (3) · Sexually Transmitted Diseases (3)
Amphotericin B (1) · Caspofungin (1) · Fluconazole (1) · acemannan (1) · posaconazole (1)
CelaCare Technologies, Inc. (1) · Hadassah Medical Organization (1) · Kerman University of Medical Sciences (1) · Merck Sharp & Dohme LLC (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Pacgen Biopharmaceuticals Corporation (1) · Schering-Plough (1)
United States (5) · Israel (2) · Argentina (1) · Belgium (1) · Canada (1) · Chile (1) · Dominican Republic (1) · Ethiopia (1) · France (1) · Germany (1) · Guatemala (1) · Honduras (1) · Iran (1) · Mexico (1) · Panama (1)
Jacqueline M. Plemons, DDS, MS (1) · Rakefet Czerninski, DMD (1) · Wheat LJ (1) · Zingman BS (1)